Cryo-EM structure of the fully-loaded asymmetric anthrax lethal toxin in its heptameric pre-pore state

PLoS Pathog. 2020 Aug 18;16(8):e1008530. doi: 10.1371/journal.ppat.1008530. eCollection 2020 Aug.

Abstract

Anthrax toxin is the major virulence factor secreted by Bacillus anthracis, causing high mortality in humans and other mammals. It consists of a membrane translocase, known as protective antigen (PA), that catalyzes the unfolding of its cytotoxic substrates lethal factor (LF) and edema factor (EF), followed by translocation into the host cell. Substrate recruitment to the heptameric PA pre-pore and subsequent translocation, however, are not well understood. Here, we report three high-resolution cryo-EM structures of the fully-loaded anthrax lethal toxin in its heptameric pre-pore state, which differ in the position and conformation of LFs. The structures reveal that three LFs interact with the heptameric PA and upon binding change their conformation to form a continuous chain of head-to-tail interactions. As a result of the underlying symmetry mismatch, one LF binding site in PA remains unoccupied. Whereas one LF directly interacts with a part of PA called α-clamp, the others do not interact with this region, indicating an intermediate state between toxin assembly and translocation. Interestingly, the interaction of the N-terminal domain with the α-clamp correlates with a higher flexibility in the C-terminal domain of the protein. Based on our data, we propose a model for toxin assembly, in which the relative position of the N-terminal α-helices in the three LFs determines which factor is translocated first.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthrax / microbiology*
  • Antigens, Bacterial / chemistry*
  • Bacillus anthracis / physiology*
  • Bacterial Toxins / chemistry*
  • Cryoelectron Microscopy / methods*
  • Humans
  • Models, Molecular
  • Protein Conformation

Substances

  • Antigens, Bacterial
  • Bacterial Toxins
  • anthrax toxin

Grants and funding

This work was supported by the Max Planck Society (to S.R.) and the European Council under the European Union’s Seventh Framework Programme (FP7/ 2007–2013) (grant no. 615984) (to S.R.). D.Q. is a fellow of Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.